{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T10:59:04Z","timestamp":1768647544517,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,3,2]],"date-time":"2012-03-02T00:00:00Z","timestamp":1330646400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Information on the health-related quality of life (HRQoL) of patients with genital warts (GW) in populations in mainland China is still limited. The aim of the study was to use a generic instrument to measure the impact of genital warts on HRQoL in men and women in this setting.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A multi-centre hospital-based cross-sectional study across 18 centers in China was conducted to interview patients using the European quality of life-5 dimension (EQ-5D) instrument; respondents' demographic and clinical data were also collected.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 1,358 GW patients (612 men, 746 women) were included in the analysis, with a mean age of 32.0 \u00b1 10.6 years. 56.4% of the patients reported some problems in the dimension of Anxiety\/Depression (highest), followed by Pain\/Discomfort (24.7%) and Mobility (3.5%). The overall visual analogue scale (VAS) score of the study population was found to be 65.2 \u00b1 22.0, and the EQ-5D index score was found to be 0.843 \u00b1 0.129 using Japanese preference weights (the Chinese preference was unavailable yet). Patients with lower VAS means and EQ-5D index scores were more often female, living in urban area, and suffering multiple GW (all p values &lt; 0.05), but the values did not differ notably by age (p values &gt; 0.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The HRQoL of patients with GW was substantially lower, compared to a national representative general population in China (VAS = ~80); the findings of different subgroups are informative for future GW prevention and control efforts.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2458-12-153","type":"journal-article","created":{"date-parts":[[2012,3,3]],"date-time":"2012-03-03T17:09:05Z","timestamp":1330794545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Impact of genital warts on health related quality of life in men and women in mainland China: a multicenter hospital-based cross-sectional study"],"prefix":"10.1186","volume":"12","author":[{"given":"Ju-Fang","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dian-Ju","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Zhen","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Chun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Jun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Xian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayinuer","family":"Niyazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-Di","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian-Kun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Lin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,2]]},"reference":[{"issue":"Suppl 12","key":"4017_CR1","doi-asserted-by":"publisher","first-page":"M1","DOI":"10.1016\/j.vaccine.2008.05.010","volume":"26","author":"DM Parkin","year":"2008","unstructured":"Parkin DM, Louie KS, Clifford G: Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region. Vaccine. 2008, 26 (Suppl 12): M1-16.","journal-title":"Vaccine"},{"key":"4017_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/sti.2009.040188","volume":"86","author":"M Pirotta","year":"2010","unstructured":"Pirotta M, Stein AN, Conway EL, Harrison C, Britt H, Garland S: Genital warts incidence and healthcare resource utilisation in Australia. Sex Transm Infect. 2010, 86: 181-186. 10.1136\/sti.2009.040188.","journal-title":"Sex Transm Infect"},{"key":"4017_CR3","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/01.olq.0000145851.76025.ad","volume":"31","author":"JE Koshiol","year":"2004","unstructured":"Koshiol JE, Laurent SA, Pimenta JM: Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States. Sex Transm Dis. 2004, 31: 748-752. 10.1097\/01.olq.0000145851.76025.ad.","journal-title":"Sex Transm Dis"},{"key":"4017_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2165\/00128071-200506040-00004","volume":"6","author":"C O'Mahony","year":"2005","unstructured":"O'Mahony C: Genital warts: current and future management options. Am J Clin Dermatol. 2005, 6: 239-243. 10.2165\/00128071-200506040-00004.","journal-title":"Am J Clin Dermatol"},{"key":"4017_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/IGC.0b013e3181ffbed8","volume":"21","author":"SM Wang","year":"2011","unstructured":"Wang SM, Shi JF, Kang DJ, Song P, Qiao YL: Chinese HPV Study Group: Impact of Human Papillomavirus Related Lesions on Quality of Life: A Multicenter Hospital-Based Study of Women in Mainland China. Int J Gynecol Cancer. 2011, 21: 182-188. 10.1097\/IGC.0b013e3181ffbed8.","journal-title":"Int J Gynecol Cancer"},{"key":"4017_CR6","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1136\/sti.2009.037028","volume":"85","author":"M Pirotta","year":"2009","unstructured":"Pirotta M, Ung L, Stein A, Conway EL, Mast TC, Fairley CK, et al: The psychosocial burden of human papillomavirus related disease and screening interventions. Sex Transm Infect. 2009, 85: 508-513. 10.1136\/sti.2009.037028.","journal-title":"Sex Transm Infect"},{"key":"4017_CR7","volume-title":"The 4th Asian Pacific Organization for Cancer Prevention General Assembly Conference, Beijing","author":"D Wang","year":"2008","unstructured":"Wang D, Shi JF, Li L, Yan SW, Sun LJ, Li CQ, et al: Measuring direct costs of treating genital warts in China [abstract]. The 4th Asian Pacific Organization for Cancer Prevention General Assembly Conference, Beijing. 2008"},{"key":"4017_CR8","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1258\/ijsa.2008.008040","volume":"19","author":"H Wang","year":"2008","unstructured":"Wang H, Qiao YL: Human papillomavirus type-distribution in condylomata acuminata of mainland China: a meta-analysis. Int J STD AIDS. 2008, 19: 680-684. 10.1258\/ijsa.2008.008040.","journal-title":"Int J STD AIDS"},{"key":"4017_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/sti.2007.029512","volume":"84","author":"S Woodhall","year":"2008","unstructured":"Woodhall S, Ramsey T, Cai C, Crouch S, Jit M, Birks Y, et al: Estimation of the impact of genital warts on health-related quality of life. Sex Transm Infect. 2008, 84: 161-166. 10.1136\/sti.2007.029512.","journal-title":"Sex Transm Infect"},{"key":"4017_CR10","volume-title":"The 21st International Papillomavirus Conference, Mexico City, Mexico","author":"E Myers","year":"2004","unstructured":"Myers E, Green S, Lipkus I: Patient preferences for health states related to HPV infection: visual analogue scales vs. time trade-off elicitation [abstract]. The 21st International Papillomavirus Conference, Mexico City, Mexico. 2004"},{"key":"4017_CR11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/OLQ.0b013e318191a55e","volume":"36","author":"C Marra","year":"2009","unstructured":"Marra C, Ogilvie G, Gastonguay L, Colley L, Taylor D, Marra F: Patients with genital warts have a decreased quality of life. Sex Transm Dis. 2009, 36: 258-260. 10.1097\/OLQ.0b013e318191a55e.","journal-title":"Sex Transm Dis"},{"key":"4017_CR12","unstructured":"EQ-5D Home page. 2011, [http:\/\/www.euroqol.org\/]"},{"key":"4017_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin R, de CF: EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001, 33: 337-343. 10.3109\/07853890109002087.","journal-title":"Ann Med"},{"key":"4017_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2165\/00019053-200017010-00002","volume":"17","author":"SJ Coons","year":"2000","unstructured":"Coons SJ, Rao S, Keininger DL, Hays RD: A comparative review of generic quality-of-life instruments. Pharmacoeconomics. 2000, 17: 13-35. 10.2165\/00019053-200017010-00002.","journal-title":"Pharmacoeconomics"},{"key":"4017_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11136-010-9762-x","volume":"20","author":"S Sun","year":"2010","unstructured":"Sun S, Chen J, Johannesson M, Kind P, Xu L, Zhang Y, et al: Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008. Qual Life Res. 2010, 20: 309-320.","journal-title":"Qual Life Res"},{"key":"4017_CR16","first-page":"49","volume":"1","author":"MH Li","year":"2009","unstructured":"Li MH, Luo N: An introduction to application of EQ-5D Chinese version. China Journal of Pharmaceutical Ecomomics. 2009, 1: 49-57.","journal-title":"China Journal of Pharmaceutical Ecomomics"},{"key":"4017_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11136-004-0612-6","volume":"14","author":"H Wang","year":"2005","unstructured":"Wang H, Kindig DA, Mullahy J: Variation in Chinese population health related quality of life: results from a EuroQol study in Beijing, China. Qual Life Res. 2005, 14: 119-132. 10.1007\/s11136-004-0612-6.","journal-title":"Qual Life Res"},{"key":"4017_CR18","first-page":"8","volume":"24","author":"LC Zhang","year":"2005","unstructured":"Zhang LC, Wang H, Wang LS, Xiao QL: Health Related Quality of Life in West Rural Population. Chinese Health Economics. 2005, 24: 8-11.","journal-title":"Chinese Health Economics"},{"key":"4017_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1477-7525-1-7","volume":"1","author":"N Luo","year":"2003","unstructured":"Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, et al: Do English and Chinese EQ-5D versions demonstrate measurement equivalence?. An exploratory study Health Qual Life Outcomes. 2003, 1: 7-10.1186\/1477-7525-1-7.","journal-title":"An exploratory study Health Qual Life Outcomes"},{"key":"4017_CR20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/hec.673","volume":"11","author":"A Tsuchiya","year":"2002","unstructured":"Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, et al: Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002, 11: 341-353. 10.1002\/hec.673.","journal-title":"Health Econ"},{"key":"4017_CR21","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan P: Modeling wfiuations for EuroQol health states. Med Care. 1997, 35: 1095-1108. 10.1097\/00005650-199711000-00002.","journal-title":"Med Care"},{"key":"4017_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00005650-200503000-00003","volume":"43","author":"JW Shaw","year":"2005","unstructured":"Shaw JW, Johnson JA, Coons SJ: US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005, 43: 203-220. 10.1097\/00005650-200503000-00003.","journal-title":"Med Care"},{"key":"4017_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2288-4-10","volume":"4","author":"L Prieto","year":"2004","unstructured":"Prieto L, Sacristan JA: What is the value of social values? The uselessness of assessing health-related quality of life through preference measures. BMC Med Res Methodol. 2004, 4: 10-10.1186\/1471-2288-4-10.","journal-title":"BMC Med Res Methodol"},{"key":"4017_CR24","doi-asserted-by":"publisher","first-page":"5399","DOI":"10.1016\/j.vaccine.2007.04.086","volume":"25","author":"M Brisson","year":"2007","unstructured":"Brisson M, Van d V, De WP, Boily MC: The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada. Vaccine. 2007, 25: 5399-5408. 10.1016\/j.vaccine.2007.04.086.","journal-title":"Vaccine"},{"key":"4017_CR25","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1056\/NEJMsa0707052","volume":"359","author":"JJ Kim","year":"2008","unstructured":"Kim JJ, Goldie SJ: Health and economic implications of HPV vaccination in the United States. N Engl J Med. 2008, 359: 821-832. 10.1056\/NEJMsa0707052.","journal-title":"N Engl J Med"},{"key":"4017_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1478-7547-6-4","volume":"6","author":"SL Kulasingam","year":"2008","unstructured":"Kulasingam SL, Benard S, Barnabas RV, Largeron N, Myers ER: Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis. Cost Eff Resour Alloc. 2008, 6: 4-10.1186\/1478-7547-6-4.","journal-title":"Cost Eff Resour Alloc"},{"key":"4017_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3201\/eid1301.060438","volume":"13","author":"EH Elbasha","year":"2007","unstructured":"Elbasha EH, Dasbach EJ, Insinga RP: Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis. 2007, 13: 28-41. 10.3201\/eid1301.060438.","journal-title":"Emerg Infect Dis"},{"key":"4017_CR28","volume-title":"Preference Measurement in Economic Analysis","author":"PL Sinnott","year":"2007","unstructured":"Sinnott PL, Joyce VR, Barnett PG: Preference Measurement in Economic Analysis. 2007, VA Palo Alto, Health Economics Resource Center: Guidebook. Menlo Park CA"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-12-153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-12-153\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-12-153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-12-153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:54:44Z","timestamp":1630522484000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-12-153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["4017"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-12-153","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,2]]},"assertion":[{"value":"20 October 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"153"}}